Gelteq Limited (NASDAQ: GELS), a clinical and science-based leader in gel-based delivery solutions, is capturing industry and investor attention with its innovative approach to nutraceuticals and healthcare products. On December 2, 2024, the company announced a 50% increase in purchase orders from its largest U.S. customer, Healthy Extracts (OTCQB: HYEX), driven by soaring demand for Gelteq’s collagen and Mynus sugar blocker gels. This milestone highlights both the rising popularity of Gelteq’s products and its successful entry into the competitive U.S. market. The partnership with Healthy Extracts is a testament to the effectiveness of Gelteq’s delivery solutions, which improve consumer experience by offering easier ingestion, better digestion, and enhanced absorption of active ingredients. As a result, Gelteq is rapidly positioning itself as a key player in the multibillion-dollar nutraceutical market, leveraging innovative technology to meet evolving consumer preferences.
Gelteq addresses a common consumer challenge: the difficulty of swallowing or digesting traditional pills and capsules. By developing gel-based formulations, the company offers an innovative alternative that ensures improved absorption, better digestion, and a convenient, enjoyable experience for consumers. Nathan Givoni, Co-Founder and CEO of Gelteq, highlighted the impact of the company’s innovation, stating, “Our partnership with Healthy Extracts is a perfect example of how our formulations create a revolutionary and convenient way for consumers to ingest products, with the added benefits of easier digestion and better absorption. We believe the increase in demand is a testament to our innovative products and a positive step forward in building long-term shareholder value.” These gel-based delivery solutions not only enhance the user experience but also solve challenges like unpalatable ingredients and dosage control. This positions Gelteq as a leader in redefining how nutraceuticals are consumed, particularly in the fast-growing U.S. market.
Healthy Extracts, known for its plant-based nutraceuticals targeting heart and brain health, has been a key partner in Gelteq’s U.S. expansion. Their collaboration reflects a shared commitment to innovation and market leadership. By incorporating Gelteq’s cutting-edge delivery technology, Healthy Extracts is positioned to expand sales channels and capture new opportunities. According to Duke Pitts, President of Healthy Extracts, “Gelteq’s advanced technology offers a cutting-edge delivery system that empowers us to capitalize on new market opportunities while delivering a more impactful experience for consumers. This partnership is poised to drive higher margins, accelerate revenue growth, and strengthen our leadership in the rapidly expanding U.S. health and wellness market.” The increased purchase order not only reflects the market’s strong demand but also signals the potential for future growth. Healthy Extracts and Gelteq plan to expand their collaboration, with new product announcements expected in early 2025.
To support its growing presence in the U.S., Gelteq has opened a new office and appointed industry veteran Adam Bendell as its U.S. President. These moves underscore the company’s commitment to penetrating the American market and strengthening its relationships with key customers like Healthy Extracts. The expansion comes at a pivotal time, as consumer preferences shift toward products that offer convenience, efficacy, and sustainability. Gelteq’s focus on gel-based delivery systems aligns perfectly with these trends, providing a competitive edge in the crowded nutraceutical landscape.
Investors have taken notice of Gelteq’s achievements. On December 2, 2024, the company’s stock soared 92.95% to close at $3.82, with trading volume of over 1.37 million shares—far surpassing its average. This surge highlights the market’s confidence in Gelteq’s growth potential and the success of its U.S. strategy. The stock has experienced a 52-week range of $1.42 to $4.98, reflecting both its recent momentum and long-term opportunities. With production of Healthy Extracts’ increased order underway and shipment expected in January 2025, Gelteq is well-positioned to sustain its upward trajectory.
Gelteq is more than just a company—it’s a catalyst for change in the nutraceutical and healthcare markets. By solving key challenges associated with traditional delivery methods, Gelteq has carved out a unique niche that resonates with both consumers and industry leaders. The company’s focus on innovation, combined with strategic partnerships like the one with Healthy Extracts, ensures a steady stream of growth opportunities. As Gelteq continues to scale its product offerings and strengthen its presence in the U.S., it remains poised to drive shareholder value and redefine how supplements and healthcare products are delivered. With new products on the horizon and a growing foothold in the lucrative U.S. market, Gelteq is a company to watch. Its gel-based delivery technology is not just meeting consumer demand—it’s setting a new standard for the industry. For investors and consumers alike, Gelteq represents a bold step forward in health and wellness innovation.
